What is the Xeljanz Lawsuit all about?
At the start, the drug emerged as a very promising medicine for patients of arthritis. However, with time, many common and severe side effects were reported with its use.
If you have used Xeljanz and suffered complications or serious side effects, you owe it to yourself and your family to contact us for a free evaluation and to determine if you are due damages for your injuries.
Information from FDA adverse event reporting system shows that since 2010, there have been about 109 reported cases of PE and fourteen deaths.
read morePfizer did not amply warn the medical community as well as consumers of the serious side effects as a result of the drug.
read moreResults of the Xeljanz ongoing clinical trial revealed the potentially fatal side effects of this not-so-wonder drug. Contact us now for a free consultation!
What we do is fight for your rights to get you the largest possible settlement to compensate you for your injuries or death. We know medical and funeral expenses are out of this world, and when you are injured through no fault of your own, we go after those responsible for your injuries and see that you're treated fairly, and with the respect and caring that you deserve.
Tofacitinib, popularly known as Xeljanz, is the first JAK (Janus Kinase) inhibitor approved by the FDA.
Doctors and pharmacists have been advised not to prescribe the medicine for now.
Consumers allege that the drug is defective and the company has failed to inform about the side effects.
Studies link Xeljanz with serious illnesses leading to hospitalization or death.
During animal trials of Xeljanz, the drug reported risks of carcinogenesis, mutagenesis, and infertility.
European regulatory agencies had certain safety concerns with the drug and were not initially approving it.
The company repeatedly claims to have no contraindications but doctors and pharmacists have been advised not to prescribe the medicine for now. Meanwhile, the plaintiffs are seeking returns for medical expenses, pain & suffering, lost wages, etc. These lawsuits are progressing at individual levels and are currently referred to the federal multidistrict litigation for consolidation.
At the start, the drug emerged as a very promising medicine for patients of arthritis. However, with time, many common and severe side effects were reported with its use.
in the first three months of controlled clinical trials, more than 2% of the patients reported upper respiratory tract infections and nasopharyngitis.
Lawsuits are progressing at individual levels and are currently referred to the federal multidistrict litigation for consolidation.